Advertisement

More articles from Erratum

You have access
CORRECTION TO “CYTOCHROME P450 EXPRESSION AND REGULATION IN CYP3A4/CYP2D6 DOUBLE TRANSGENIC HUMANIZED MICE”
Drug Metabolism and Disposition July 2009, 37 (7) 1563; DOI: https://doi.org/10.1124/dmd.37.7.1563
You have access
CORRECTION TO “A COMBINED MODEL FOR PREDICTING CYP3A4 CLINICAL NET DRUG-DRUG INTERACTION BASED ON CYP3A4 INHIBITION, INACTIVATION, AND INDUCTION DETERMINED IN VITRO”
Drug Metabolism and Disposition September 2008, 36 (9) 1975; DOI: https://doi.org/10.1124/dmd.36.9.1975
You have access
CORRECTION TO “IDENTIFICATION AND CHARACTERIZATION OF POTENT CYP2B6 INHIBITORS IN WOOHWANGCHEONGSIMWON SUSPENSION, AN HERBAL PREPARATION USED IN THE TREATMENT AND PREVENTION OF APOPLEXY IN KOREA AND CHINA”
Drug Metabolism and Disposition August 2008, 36 (8) 1736; DOI: https://doi.org/10.1124/dmd.36.8.1736
You have access
CORRECTION TO “THE DEVELOPMENT OF DRUG METABOLISM RESEARCH AS EXPRESSED IN THE PUBLICATIONS OF ASPET: PART 1, 1909–1958”
Drug Metabolism and Disposition March 2008, 36 (3) 622; DOI: https://doi.org/10.1124/dmd.36.3.622
You have access
CORRECTION TO “USE OF ISOLATED HEPATOCYTE PREPARATIONS FOR CYTOCHROME P450 INHIBITION STUDIES: COMPARISON WITH MICROSOMES FOR K_I DETERMINATION”
Drug Metabolism and Disposition January 2008, 36 (1) 203; DOI: https://doi.org/10.1124/dmd.36.1.203
You have access
CORRECTION TO “IN VITRO METABOLIC STUDY OF TEMSIROLIMUS: PREPARATION, ISOLATION, AND IDENTIFICATION OF THE METABOLITES”
Drug Metabolism and Disposition November 2007, 35 (11) 2138; DOI: https://doi.org/10.1124/dmd.35.11.2138
You have access
CORRECTION TO “THREE-DIMENSIONAL QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP ANALYSIS OF HUMAN CYP51 INHIBITORS”
Drug Metabolism and Disposition July 2007, 35 (7) 1246; DOI: https://doi.org/10.1124/dmd.35.7.1246
You have access
Correction to “Stereoselective Metabolism of Endosulfan by Human Liver Microsomes and Human Cytochrome P540 Isoforms”
Drug Metabolism and Disposition May 2007, 35 (5) 829-830; DOI: https://doi.org/10.1124/dmd.35.5.829
You have access
CORRECTION TO “NEUROTOXIC PYRIDINIUM METABOLITES OF HALOPERIDOL ARE SUBSTRATES OF HUMAN ORGANIC CATION TRANSPORTERS”
Drug Metabolism and Disposition December 2006, 34 (12) 2117; DOI: https://doi.org/10.1124/dmd.34.12.2117
You have access
Correction To “Glutathione S-Transferase Omega 1 and Omega 2 Pharmacogenomics”
Drug Metabolism and Disposition September 2006, 34 (9) 1666; DOI: https://doi.org/10.1124/dmd.34.9.1666

Pages